Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Impact of Adherence and Highly Active Antiretroviral Therapy on Survival in HIV-Infected Patients

Dados Bibliográficos

ID23356282
AutoresPatricia García De Olalla (0000-0002-2293-3560, Universitat Autonòma de Barcelona, autor correspondente), Hernando Knobel (0000-0003-3186-6416, Hospital Del Mar), Alexia Carmona (Hospital Del Mar), Ana Guelar (0000-0001-6697-2652, Hospital Del Mar), José L López-Colomés (Hospital Del Mar), Joan A Caylà (0000-0003-3891-111X, Universitat Autonòma de Barcelona, autor correspondente)
Ano2002
Volume30
Fascículo1
Páginas105-110
Data de publicação2002-05-01
Peer ReviewedSim
Open AccessNão
TipoARTICLE
PeriódicoJAIDS Journal of Acquired Immune Deficiency Syndromes (JOURNAL)
Identificadores do periódicoISSN: 1525-4135 • E-ISSN: 1944-7884
EditoraOvid Technologies (Wolters Kluwer Health) (PUBLISHER)
DOI10.1097/00042560-200205010-00014
PMID12048370
OpenAlexW1993062623
IdiomaEN
Citações recebidas78
Referências citadas30

OBJECTIVES: To assess the effect of antiretroviral therapy (ART) adherence on survival in HIV-infected patients. DESIGN: Cohort study at a single hospital in Barcelona, Spain. METHODS: Data on HIV-infected patients older than 18 years of age who began ART during the period 1990 to 1999 were analyzed. Patients were considered nonadherent if the total dose of antiretroviral drug was less than 90% of that prescribed. Adherence was assessed through self-report and hospital pharmacy appointments. Cox regression with time-dependent variables was used. RESULTS: A total of 1219 patients were included. The first ART was with monotherapy in 23.7% of cases, with two drugs in 30.5%, and with triple therapy in 45.8%. In multivariate analysis, the variables that presented significant differences with respect to mortality were clinical stage at the beginning of treatment (AIDS: relative hazard (RH) = 2.97; 95% confidence interval [CI]: 2.14-4.13), CD4 cell count (<200 cells/microL: RH = 5.89; CI: 3.44-10.10), type of treatment (monotherapy: RH = 9.76; CI: 4.56-20.90; bi-therapy: RH = 9.12; CI: 4.23-19.64), and adherence (nonadherence: RH = 3.87; CI: 1.77-8.46). CONCLUSIONS: The modifiable factors most strongly associated with survival were type of treatment and adherence. It would be desirable to accompany therapy with intervention strategies intended to improve adherence.

Antiretroviral therapy · Cohort · Cohort study · Combination therapy · Confidence interval · Hazard ratio · Human immunodeficiency virus (HIV) · Multivariate analysis · Pharmacotherapy · Proportional hazards model · Retrospective cohort study · Survival analysis · Viral load · HIV-related health complications and treatments · HIV/AIDS drug development and treatment · HIV/AIDS Research and Interventions · Immunology · Internal Medicine · Medicine

  • Food Insecurity as a Barrier to Sustained Antiretroviral Therapy Adherence in Uganda

    Open Access•Sheri D Weiser, David M Tuller et al.•PLoS ONE•2010

  • Unplanned antiretroviral treatment interruptions in southern Africa

    Open Access•Nina Veenstra, Alan Whiteside et al.•Globalization and Health•2010

  • Adesão em HIV/Aids

    Open Access•Camila Peixoto Pessôa Guerra, Eliane Maria Fleury Seidl•Psicologia em Estudo•2010

  • Validation and Abbreviation of an HIV Stigma Scale in an Adult Spanish-Speaking Population in Urban Peru

    Open Access•Molly F Franke, Maribel Muñoz et al.•AIDS and Behavior•2008

  • Comparison of Pharmacy-Based Measures of Adherence to Antiretroviral Therapy as Predictors of Virological Failure

    Open Access•Cassidy Henegar, Cassidy E Henegar et al.•AIDS and Behavior•2014

  • Abuse and Resilience in Relation to Haart Medication Adherence and HIV Viral Load Among Women with HIV in the United States

    Sannisha K Dale, Sannisha Dale et al.•AIDS Patient Care and STDs•2014

  • Adherence to Haart Regimens

    Margaret Chesney, Margaret A Chesney•AIDS Patient Care and STDs•2003

  • Less Than 95% Adherence to Nonnucleoside Reverse‐Transcriptase Inhibitor Therapy Can Lead to Viral Suppression

    David R Bangsberg•Clinical Infectious Diseases•2006

  • Barriers to HIV Medication Adherence

    Tiara C Willie, Nicole M Overstreet et al.•Behavioral Medicine•2015

  • How am I going to live?”

    Open Access•Sarah Maccarthy, Uzaib Saya et al.•BMC Public Health•2018

  • The DREAM model's effectiveness in health promotion of Aids patients in Africa

    Open Access•Massimo Magnano San Lio, S Mancinelli et al.•Health Promotion International•2008

  • Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users

    Steven A Safren, Conall O’cleirigh et al.•Journal of Consulting and…•2012

  • Exploring the Communication of Social Support within Virtual Communities

    Open Access•Phoenix K H Mo, Neil S Coulson•CyberPsychology & Behavior•2008

  • Measuring Adherence to Antiretroviral Therapy in a Diverse Population Using a Visual Analogue Scale

    Thomas P Giordano, Diego Guzmán et al.•HIV Clinical Trials•2004

  • Barriers to Antiretroviral Adherence for Patients Living with HIV Infection and Aids in Botswana

    Sheri D Weiser, Sheri Weiser et al.•JAIDS Journal of Acquired Immune…•2003

  • Longitudinal assessment of associations between food insecurity, antiretroviral adherence and HIV treatment outcomes in rural Uganda

    Sheri D Weiser, Kartika Palar et al.•AIDS•2014

  • Prevalence of DSM-IV-Defined Mood, Anxiety, and Substance Use Disorders in an HIV Clinic in the Southeastern United States

    Brian W Pence, William C Miller et al.•JAIDS Journal of Acquired Immune…•2006

  • Multiple Validated Measures of Adherence Indicate High Levels of Adherence to Generic HIV Antiretroviral Therapy in a Resource-Limited Setting

    Jessica H Oyugi, Jayne Byakika-Tusiime et al.•JAIDS Journal of Acquired Immune…•2004

  • Adherence to Highly Active Antiretroviral Therapy (Haart)

    Open Access•Carmen Ortego, Tania B Huedo-Medina et al.•AIDS and Behavior•2011

  • Self-Report Measures of Antiretroviral Therapy Adherence

    Open Access•Jane M Simoni, Ann E Kurth et al.•AIDS and Behavior•2006

  • Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users

    Barbara J Turner, Christine Laine et al.•Journal of General Internal…•2003

  • Depression and HIV/Aids Treatment Nonadherence

    Jeffrey S Gonzalez, Abigail W Batchelder et al.•JAIDS Journal of Acquired Immune…•2011

  • Couple-focused support to improve HIV medication adherence

    Robert H Remien, Michael J Stirratt et al.•AIDS•2005

  • Adherence to antiretroviral therapy in adolescents living with HIV

    Sung-Hee Kim, Sarah M Gerver et al.•AIDS•2014

  • Relationship with Health Care Provider and Adherence to HIV Medications

    Open Access•Craig Demmer•Psychological Reports•2003

  • Stopping, starting, and sustaining HIV antiretroviral therapy

    Open Access•Marya Gwadz, Charles M Cleland et al.•BMC Public Health•2021

  • Relationship With Health Care Provider and Adherence to Hiv Medications

    Craig Demmer•Psychological Reports•2003

  • Hunger and Adherence to Antiretroviral Therapy

    Open Access•Amon Exavery, 一浩 栗崎 et al.•Frontiers in Public Health•2022

  • Living to suffer? Quality of life factors associated with adherence to antiretroviral therapy in Spanish HIV-infected children

    Dolores García-Alonso, María Ángeles Muñoz‐Fernández et al.•Vulnerable Children and Youth…•2015

  • HIV Testing Rates, Testing Locations, and Healthcare Utilization among Urban African-American Men

    Open Access•Andrew E Petroll, Wayne Difranceisco et al.•Journal of Urban Health•2008

  • Comprehensive and Medically Appropriate Food Support Is Associated with Improved HIV and Diabetes Health

    Open Access•Kartika Palar, Tessa M Nápoles et al.•Journal of Urban Health•2017

  • Viral suppression among persons living with HIV in Trinidad & Tobago

    Open Access•Robert J Edwards, Elena Cyrus et al.•Global Public Health•2019

  • Monitoring Adherence to HIV Antiretroviral Therapy in Routine Clinical Practice

    Open Access•David R Bangsberg•AIDS and Behavior•2006

  • Effect of a Clinic-Wide Social Marketing Campaign to Improve Adherence to Antiretroviral Therapy for HIV Infection

    Open Access•Thomas P Giordano, Sonia Rodríguez et al.•AIDS and Behavior•2012

  • Lack of Association between Retrospectively Collected Pharmacy Refill Data and Electronic Drug Monitoring of Antiretroviral Adherence

    Open Access•Trisha Acri, Thomas R TenHave et al.•AIDS and Behavior•2008

  • Substance Use Predictors of Poor Medication Adherence

    Open Access•Adam Gonzalez, Matthew J Mimiaga et al.•AIDS and Behavior•2012

  • Matching Social Support to Individual Needs

    Open Access•Maribel Muñoz, Jaime Bayona et al.•AIDS and Behavior•2010

  • Depressive Symptoms, Lifestyle Structure, and ART Adherence Among HIV-Infected Individuals

    Open Access•Jessica F Magidson, Aaron J Blashill et al.•AIDS and Behavior•2014

  • Patient?Clinician Relationships and Treatment System Effects on HIV Medication Adherence

    Open Access•Karen S Ingersoll, Karen Ingersoll et al.•AIDS and Behavior•2005

  • Personal Health Record Use and Its Association with Antiretroviral Adherence

    Open Access•D Keith McInnes, Stephanie L Shimada et al.•AIDS and Behavior•2013

  • Evaluation of the Single-Item Self-Rating Adherence Scale for Use in Routine Clinical Care of People Living with HIV

    Open Access•Betsy J Feldman, Rob Jay Fredericksen et al.•AIDS and Behavior•2012

  • People with HIV in Haart-Era Russia

    Open Access•Yuri A Amirkhanian, Jeffrey A Kelly et al.•AIDS and Behavior•2010

  • Primary Relationships, HIV Treatment Adherence, and Virologic Control

    Open Access•Mallory O Johnson, Samantha E Dilworth et al.•AIDS and Behavior•2011

  • Antiretroviral Therapy Adherence and Use of an Electronic Shared Medical Record Among People Living with HIV

    Open Access•Parya Saberi, Sheryl L Catz et al.•AIDS and Behavior•2015

  • Unannounced Telephone-Based Pill Counts

    Open Access•Rob Jay Fredericksen, R Fredericksen et al.•AIDS and Behavior•2014

  • Drug Use and Medication Adherence among HIV-1 Infected Individuals

    Open Access•Charles H Hinkin, Terry R Barclay et al.•AIDS and Behavior•2006

  • Perinatal Depression and Anxiety in Women with and without Human Immunodeficiency Virus Infection

    Open Access•Erika Aaron, Alexa Bonacquisti et al.•Women s Health Issues•2015

  • Improving adherence to antiretroviral treatment in Uganda with a low-resource facility-based intervention

    Open Access•Celestino Obua, Joshua Kayiwa et al.•Global Health Action•2014

  • Intentionality of medication non-adherence among individuals living with HIV/Aids in Hong Kong

    Phoenix K H Mo, Winnie W S Mak•AIDS Care•2009

  • Voices on adherence to ART in Ethiopia and Uganda

    Annelie K Gusdal, Celestino Obua et al.•AIDS Care•2009

  • Impact of transitioning from HIV clinical trials to routine medical care on clinical outcomes and patient perceptions

    Baligh R Yehia, Judith A Long et al.•AIDS Care•2012

  • Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate in antiretroviral treatment-naive adults infected with HIV-1 through 48 weeks of treatment

    Ed L Wilkins, Calvin J Cohen et al.•AIDS Care•2016

  • Incidences and risk factors of first-line Haart discontinuation

    M Keita, Isabelle Perbost et al.•AIDS Care•2014

  • Peer counselors' role in supporting patients' adherence to ART in Ethiopia and Uganda

    Annelie K Gusdal, Celestino Obua et al.•AIDS Care•2011

  • Multidisciplinary care model for HIV improves treatment outcome

    Ali Elgalib, Halima Al-Sawafi et al.•AIDS Care•2018

  • Reliability and validity of the Functional Assessment of Human Immunodeficiency Virus Infection (Fahi) in patients with drug and alcohol use disorders

    Shannon Byrne, Nancy M Petry•AIDS Care•2013

  • Alcohol use and HIV disease management

    Sarah E Woolf-King, Torsten B Neilands et al.•AIDS Care•2014

  • The relationship between depression, anxiety and medication adherence among patients receiving antiretroviral treatment in South Africa

    Adriaan Nel, Ashraf Kagee•AIDS Care•2013

  • The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy

    Imad Al-Dakkak, Seema Patel et al.•AIDS Care•2013

  • Treatment partners and adherence to Haart in Central Mozambique

    Benjamin A Stubbs, Mark A Micek et al.•AIDS Care•2009

  • Adherence in people living with HIV/Aids, mental illness, and chemical dependency

    Karina K Uldall, Nancy Palmer et al.•AIDS Care•2004

  • Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence

    Sharon Mannheimer, S B Mannheimer et al.•AIDS Care•2005

  • Antiretroviral therapy (ART) adherence and correlates to nonadherence among people on ART in Estonia

    Anneli Uusküla, Kaja-Triin Laisaar et al.•AIDS Care•2012

  • Differential predictors of ART adherence among HIV-monoinfected versus HIV/HCV-coinfected individuals

    Paul A Shuper, Narges Joharchi et al.•AIDS Care•2016

  • The cost of HIV medication adherence support interventions

    Bruce R Schackman, Ruth Finkelstein et al.•AIDS Care•2005

  • Model of socio-cultural dimensions involved in adherence to antiretroviral therapy for HIV/Aids in public health care centers in Chile

    Valeria Stuardo Ávila, Jose Manuel Manriquez Urbina et al.•AIDS Care•2016

  • The Case adherence index

    Sharon Mannheimer, S B Mannheimer et al.•AIDS Care•2006

  • An evaluation of the impact of a community-based adherence support programme on ART outcomes in selected government HIV treatment sites in South Africa

    Jude Igumbor, J O Igumbor et al.•AIDS Care•2011

  • Predictors of early mortality in a cohort of HIV-infected children receiving high active antiretroviral treatment in public hospitals in Ethiopia

    Getachew Ebissa, Negusse Deyessa et al.•AIDS Care•2015

  • Adherence to antiretroviral therapy in a context of universal access, in Rio de Janeiro, Brazil

    Robert H Remien, Francisco I Bastos et al.•AIDS Care•2007

  • An empirical test of the Information, Motivation and Behavioral Skills model of antiretroviral therapy adherence

    K Rivet Amico, José Toro-Alfonso et al.•AIDS Care•2005

  • Sex differences in adherence to highly active antiretroviral therapy

    C Ortego, T B Huedo-Medina et al.•AIDS Care•2012

  • Social factors affecting ART adherence in rural settings in Zambia

    Ikuma Nozaki, Christopher Dube et al.•AIDS Care•2011

  • A qualitative study of persons who are 100% adherent to antiretroviral therapy

    Michael Lewis, M P Lewis et al.•AIDS Care•2006

  • Intricacies and inter-relationships between HIV disclosure and Haart

    Robert Klitzman, R L Klitzman et al.•AIDS Care•2004

  • Someone who is in this thing that I am suffering from”

    Open Access•Jessica F Magidson, John A Joska et al.•International Journal of Drug…•2019

  • Depression, adherence and attrition from care in HIV-infected adults receiving antiretroviral therapy

    Alexis A Krumme, Felix Kaigamba et al.•Journal of Epidemiology and…•2015

  • The Impact of Integrated HIV Care on Patient Health Outcomes

    Tuyen Hoang, Matthew Bidwell Goetz et al.•Medical Care•2009

  • Non-adherence to highly active antiretroviral therapy predicts progression to Aids

    David R Bangsberg, Sharon Perry et al.•AIDS•2001

  • A Comparison Study of Multiple Measures of Adherence to HIV Protease Inhibitors

    Open Access•Honghu Liu, Carol E Golin et al.•Annals of Internal Medicine•2001

  • Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection

    Open Access•David L Paterson, Susan Swindells et al.•Annals of Internal Medicine•2000

Obras citantes distintas78
Citações por ano3,39
Intervalo de citações2003 - 2022 (20)
Velocidade de citaçãohistorical
Altamente citadoNão
Tipos de citaçãoNeutras: 69
Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae